Ultrahuman Buys viO HealthTech to Boost Cycle & Ovulation Tracking
▼ Summary
– Ultrahuman is acquiring viO HealthTech to enhance its smart ring with advanced cycle and ovulation tracking features, though financial details were not disclosed.
– The new “Cycle and Ovulation Pro” plug-in for the Ultrahuman Ring AIR offers fertility planning, ovulation confirmation, and symptom logging for long-term wellness insights.
– The plug-in uses a 15-year-developed temperature-sensing algorithm from viO’s OvuSense, trained on over 260,000 cycles with medical-grade sensors.
– Ultrahuman aims to address diverse menstrual cycle patterns, including conditions like PCOS and endometriosis, which are often overlooked by standard tracking platforms.
– The premium plug-in is available for $3.99/month or $39.99/year in select regions, with plans to expand to more markets in the future.
Ultrahuman has expanded its health-tracking capabilities by acquiring viO HealthTech, a move that brings advanced menstrual and ovulation monitoring to its smart ring platform. The deal, announced recently, integrates viO’s proven fertility technology into Ultrahuman’s ecosystem, offering users more precise cycle tracking and personalized health insights. While financial specifics remain undisclosed, the acquisition underscores Ultrahuman’s commitment to addressing diverse women’s health needs.
A new feature called Cycle and Ovulation Pro will debut as a premium add-on for the Ultrahuman Ring AIR. This tool leverages viO’s temperature-sensing algorithm, refined over 15 years using data from over 260,000 cycles captured by medical-grade sensors. Unlike basic period trackers, the technology adapts to irregular cycles and conditions like PCOS or endometriosis, providing ovulation confirmation and fertility planning support. Users can also log symptoms and moods to identify long-term wellness patterns.
The existing free version, Cycle & Ovulation PowerPlug, will continue offering basic tracking, but the Pro upgrade delivers deeper analysis for $3.99 monthly or $39.99 annually in the U.S., U.K., EU, Australia, and Canada. Expansion to additional regions is planned.
Rob Milnes, CEO of viO HealthTech, emphasized the broader impact of wearables in health innovation, noting the partnership will make OvuSense’s insights accessible to more users. Ultrahuman’s focus on inclusivity aims to bridge gaps for those underserved by conventional 28-day cycle assumptions.
By combining finger-based temperature tracking with viO’s clinical-grade algorithms, the Ultrahuman Ring AIR promises a more tailored approach to reproductive health, a significant step forward for wearable technology.
The integration highlights how wearable tech is evolving beyond fitness metrics to address specialized health concerns, offering data-driven solutions for historically overlooked areas like women’s wellness.
With this acquisition, Ultrahuman solidifies its position in the competitive health-tech space, proving that innovation isn’t just about hardware, it’s about solving real-world health challenges with precision and empathy.
(Source: TechCrunch)
